Category: Uncategorized

Eli Lilly announced its plan to acquire an experimental cancer therapy from Scorpion Therapeutics for a total consideration of up... Read more

The Swiss pharmaceutical giant Novartis has reached an agreement to acquire Anthos Therapeutics, a biopharmaceutical firm majority-owned by the life... Read more

Merck has successfully completed its previously announced $3.4 billion acquisition of SpringWorks Therapeutics, a biopharmaceutical company based in Stamford, Connecticut.... Read more

Roche has announced its plan to acquire 89bio, a San Francisco-based biotechnology firm, in a strategic move valued at approximately... Read more

Global pharmaceutical giant Novo Nordisk has significantly strengthened its position in the treatment landscape for Metabolic Dysfunction-associated Steatohepatitis (MASH) with... Read more

Merck successfully completed its $10 billion acquisition of Verona Pharma last month, a deal notable for the absence of a... Read more

Global healthcare leader Johnson & Johnson (J&J) commenced the J.P. Morgan Healthcare Conference by announcing its intent to acquire Intra-Cellular... Read more

The global pharmaceutical corporation Pfizer Inc. has announced the successful conclusion of its acquisition of the clinical-stage biotechnology firm, Metsera,... Read more